JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB5473

Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody

5

(10 Reviews)

|

(49 Publications)

Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody (ab5473) is a rabbit polyclonal antibody detecting VEGF Receptor 2 in Western Blot. Suitable for Human.

- Over 30 publications
- Trusted since 2003

View Alternative Names

CD309, FLK1, VEGFR2, KDR, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1, FLK-1

2 Images
Western blot - Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody (AB5473)
  • WB

Supplier Data

Western blot - Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody (AB5473)

A 150 kDa band corresponding to VEGFR (pYpY1054/1059) was observed across cell lines tested.

Protein samples were electrophoresed using Novex® NuPAGE® 10 % Bis-Tris gel, XCell SureLock™ Electrophoresis System and Novex® Sharp Pre-Stained Protein Standard.

Resolved proteins were then transferred onto a nitrocellulose membrane by over night wet transfer.

Chemiluminescent detection was performed using Pierce™ ECL Western Blotting Substrate.

All lanes:

Western blot - Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody (ab5473) at 1/1000 dilution

Lanes 1 - 4:

Goat anti-rabbit IgG HRP conjugate at 1/5000 dilution

Lane 1:

HUVEC (Human umbilical vein endothelial cell line) whole cell extract at 30 µg

Lane 2:

HUVEC cells treated with 25ng/ml VEGF for 5 minutes at 30 µg

Lane 3:

MDA-MB-231 (human breast adenocarcinoma cell line) whole cell extract at 30 µg

Lane 4:

MCF7 (human breast adenocarcinoma cell line) whole cell extract at 30 µg

Predicted band size: 151 kDa

false

Immunocytochemistry - Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody (AB5473)
  • ICC

Supplier Data

Immunocytochemistry - Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody (AB5473)

Immunofluorescence analysis of HUVEC cells labelling VEGF Receptor 2 (phospho Y1054 + Y1059) (PAnel a : green) using ab5473 at 2 ug/ml in 0.1% BSA for 3 hours at room temperature, follwed by Alexa Fluor® 488-conjugated Goat anti-rabbit IgG polyclonal at 1/2000 dilution. Pbel b : Nuclei stained with DAPI (blue), Panel c : F-actin stained with Alexa Fluor® 555 Rhodamine Phalloidin (red), Panel d : Merged images. The images were captured at 60X magnification.

Prior antibody incubation, HUVEC (Human umbilical vein endothelial cell line) cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes and blocked with 1% BSA for 1 hour at room temperature, followed by treatment with 100 ng of VEGF for 30 minutes. Assay was done on 90% confluent log phase HUVEC cells.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "1/250", "ICC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "ICC-species-checked": "predicted", "ICC-species-dilution-info": "", "ICC-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "ICC-species-checked": "predicted", "ICC-species-dilution-info": "", "ICC-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) antibody (ab5473) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB) in Human samples.

Trusted by the scientific community
Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) (ab5473) was first used in a scientific publication in 2003 and has been cited over 30 times in peer-reviewed journals.

Reviewed by scientists
Anti-VEGF Receptor 2 (phospho Y1054 + Y1059) (ab5473) has over 10 independent reviews from customers.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
The antibody has been negatively preadsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated VEGFR 2. The final product is generated by affinity chromatography using a VEGFR 2 derived peptide that is phosphorylated at Tyrosines 1054 and 1059.
Storage buffer
pH: 7.3 Preservative: 0.05% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

VEGF Receptor 2 also known as KDR or Flk-1 is a receptor tyrosine kinase important for mediating the effects of vascular endothelial growth factor (VEGF). This protein has a mass of approximately 150 kDa. It mostly expresses in vascular endothelial cells playing a primary role in the formation of blood vessels. The receptor can also be found in various non-endothelial tissues though in smaller amounts indicating its broad functional roles outside of the vascular system.
Biological function summary

VEGF Receptor 2 is important for angiogenesis and vascular permeability. It is part of the VEGF receptor family which also includes VEGF Receptors 1 and 3 forming a complex interaction network. Upon binding with VEGF it phosphorylates key proteins to initiate signals that regulate endothelial cell migration proliferation and survival. The receptor's function is critical for normal developmental processes and wound healing as well.

Pathways

VEGF Receptor 2 is especially important within the angiogenesis and vascular permeability pathways. It plays a central role in the VEGF signaling pathway alongside proteins like VEGF A which is the primary ligand for the receptor. The signaling through this receptor modulates various downstream proteins through phosphorylation linking it to pathways that control cellular responses essential for blood vessel formation and maintenance.

VEGF Receptor 2 is significantly linked with cancer and age-related macular degeneration. In the context of cancer the overexpression or dysregulation of VEGF and its receptors including VEGF Receptor 2 often leads to enhanced tumor angiogenesis promoting tumor growth and metastasis. Additionally the receptor interacts with other proteins in pathological states such as CD309 in endothelial cell-based assays which are used for research like flow cytometry and ELISA to monitor VEGF Receptor 2 activity and its impact on diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 and isoform 3, may function as decoy receptors for VEGFA, VEGFC and/or VEGFD. Isoform 2 plays an important role as negative regulator of VEGFA- and VEGFC-mediated lymphangiogenesis by limiting the amount of free VEGFA and/or VEGFC and preventing their binding to FLT4. Modulates FLT1 and FLT4 signaling by forming heterodimers. Binding of vascular growth factors to isoform 1 leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, reorganization of the actin cytoskeleton and activation of PTK2/FAK1. Required for VEGFA-mediated induction of NOS2 and NOS3, leading to the production of the signaling molecule nitric oxide (NO) by endothelial cells. Phosphorylates PLCG1. Promotes phosphorylation of FYN, NCK1, NOS3, PIK3R1, PTK2/FAK1 and SRC.
See full target information KDR phospho Y1054 + Y1059

Publications (49)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in bioengineering and biotechnology 13:1606230 PubMed40843448

2025

Macula densa cell angiogenic mechanisms and their therapeutic potential in kidney disease.

Applications

Unspecified application

Species

Unspecified reactive species

Georgina Gyarmati,Dorinne Desposito,Anne Riquier-Brison,Alejandra Becerra Calderon,Greta Trogen,Audrey Izuhara,Michifumi Yamashita,János Peti-Peterdi

Materials today. Bio 33:102015 PubMed40677405

2025

BMSCs-targeting piezoelectric stimulation and immunomodulatory dual-functional hydrogel for promoting diabetic bone regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Jintao Dong,Wengang Dong,Huijie Ran,Dongxu Wu,Xinli Wang,Hongli Chen,Jiahao Cao,Xu Wang,Xinsen Lin,Wei Lei,Tianji Wang,Yafei Feng

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2404218 PubMed39206706

2024

Light-Activated Anti-Vascular Combination Therapy against Choroidal Neovascularization.

Applications

Unspecified application

Species

Unspecified reactive species

Shuting Xu,Jia Li,Kaiqi Long,Xiaoling Liang,Weiping Wang

Advanced functional materials 33: PubMed38558868

2024

Injectable Shear-Thinning Hydrogels with Sclerosing and Matrix Metalloproteinase Modulatory Properties for the Treatment of Vascular Malformations.

Applications

Unspecified application

Species

Unspecified reactive species

Fatemeh Zehtabi,Ankit Gangrade,Kaylee Tseng,Reihaneh Haghniaz,Reza Abasgholizadeh,Hossein Montazerian,Danial Khorsandi,Jamal Bahari,Amir Ahari,Neda Mohaghegh,Negar Hosseinzadeh Kouchehbaghi,Kalpana Mandal,Marvin Mecwan,Ahmad Rashad,Natan Roberto de Barros,Youngjoo Byun,Menekse Ermis,Han-Jun Kim,Ali Khademhosseini

Cellular and molecular gastroenterology and hepatology 17:1039-1061 PubMed38467191

2024

Endothelial Slc35a1 Deficiency Causes Loss of LSEC Identity and Exacerbates Neonatal Lipid Deposition in the Liver in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Bin Zuo,Fei Yang,Lulu Huang,Jingjing Han,Tianyi Li,Zhenni Ma,Lijuan Cao,Yun Li,Xia Bai,Miao Jiang,Yang He,Lijun Xia

Frontiers in medicine 10:1095344 PubMed36744132

2023

LDP alleviates TKI-induced proteinuria through reversing the expression of RelA in renal tissues.

Applications

Unspecified application

Species

Unspecified reactive species

Zhou Fu,Su Zhang,Xiaoying Gu,Tao Guan,Chengmeng Wang,Jiaqi Zhang,Yun Wang,Hua Guo,Lu Wang,Ti Zhang

Advanced healthcare materials 12:e2202210 PubMed36465008

2023

Spatiotemporal Regulation of Injectable Heterogeneous Silk Gel Scaffolds for Accelerating Guided Vertebral Repair.

Applications

Unspecified application

Species

Unspecified reactive species

Tianji Wang,Keyin Liu,Jing Wang,Geng Xiang,Xiaofan Hu,Hao Bai,Wei Lei,Tiger H Tao,Yafei Feng

Molecular medicine (Cambridge, Mass.) 28:87 PubMed35922746

2022

Activation of the sigma-1 receptor exerts cardioprotection in a rodent model of chronic heart failure by stimulation of angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Zhao,Xin Liu,Xiuhuan Chen,Xueyu Han,Yazhou Sun,Yuhong Fo,Xiukun Wang,Chuan Qu,Bo Yang

International journal of molecular sciences 23: PubMed35743202

2022

Neuroprotective Effects of VEGF in the Enteric Nervous System.

Applications

Unspecified application

Species

Unspecified reactive species

Ines Hecking,Lennart Norman Stegemann,Verena Theis,Matthias Vorgerd,Veronika Matschke,Sarah Stahlke,Carsten Theiss

Journal of oncology 2022:3744560 PubMed35444695

2022

CircLATS2 Regulates miR-520a-3p/E2F7/p-VEGFR2 Signaling Pathway to Promote Hepatocellular Carcinoma Progression and Angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Yefeng Wu,Jianmao Yuan,Zhengbin Tu,Huahua Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com